- Home
- CELC vs ZKH Comparison
CELC vs ZKH Comparison
Compare CELC & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- ZKH
- Stock Information
- Founded
- CELC 2011
- ZKH 1998
- Country
- CELC United States
- ZKH China
- Employees
- CELC N/A
- ZKH N/A
- Industry
- CELC Medical Specialities
- ZKH
- Sector
- CELC Health Care
- ZKH
- Exchange
- CELC Nasdaq
- ZKH Nasdaq
- Market Cap
- CELC 440.0M
- ZKH 474.0M
- IPO Year
- CELC 2017
- ZKH 2023
- Fundamental
- Price
- CELC $51.79
- ZKH $3.02
- Analyst Decision
- CELC Strong Buy
- ZKH Buy
- Analyst Count
- CELC 6
- ZKH 1
- Target Price
- CELC $46.50
- ZKH $4.00
- AVG Volume (30 Days)
- CELC 2.9M
- ZKH 472.4K
- Earning Date
- CELC 08-14-2025
- ZKH 08-22-2025
- Dividend Yield
- CELC N/A
- ZKH N/A
- EPS Growth
- CELC N/A
- ZKH N/A
- EPS
- CELC N/A
- ZKH N/A
- Revenue
- CELC N/A
- ZKH $1,217,705,644.00
- Revenue This Year
- CELC N/A
- ZKH $11.72
- Revenue Next Year
- CELC N/A
- ZKH $10.57
- P/E Ratio
- CELC N/A
- ZKH N/A
- Revenue Growth
- CELC N/A
- ZKH 2.24
- 52 Week Low
- CELC $7.58
- ZKH $2.50
- 52 Week High
- CELC $53.70
- ZKH $4.10
- Technical
- Relative Strength Index (RSI)
- CELC 92.18
- ZKH 49.39
- Support Level
- CELC $38.00
- ZKH $2.90
- Resistance Level
- CELC $53.40
- ZKH $3.03
- Average True Range (ATR)
- CELC 3.33
- ZKH 0.14
- MACD
- CELC 0.92
- ZKH -0.00
- Stochastic Oscillator
- CELC 89.44
- ZKH 76.19
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.